The importance of arginine mutation for the evolutionary structure and function of phenylalanine hydroxylase gene

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 601, Issue 1-2, 2006, Pages 39-45

  Lüleyap, H Ümit ^a   Alptekin, Davut ^a   Pazarbaşi, Ayfer ^a   Kasap, Mulkiye ^a   Kasap, Halil ^a   Demirhindi, Hakan ^a   Mungan, Neslihan ^a   Özer, Güler ^a   Froster, Ursula G ^b  

^a CUKUROVA UNIVERSITY   (Turkey)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Evolution; Importance of arginine; PAH gene; Phenylketonuria

Indexed keywords

ARGININE; HISTONE; PHENYLALANINE 4 MONOOXYGENASE; RNA BINDING PROTEIN; SIGNAL RECOGNITION PARTICLE;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA POLYMORPHISM; ENZYME ACTIVE SITE; ENZYME POLYMORPHISM; EXON; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC SCREENING; HUMAN; MOLECULAR EVOLUTION; MUTATION RATE; NUCLEOTIDE SEQUENCE; PHENYLKETONURIA; PRIORITY JOURNAL; RNA TRANSLATION; SEQUENCE ANALYSIS;

ALLELES; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; EXONS; GENE FREQUENCY; HUMANS; MUTATION; PHENYLALANINE HYDROXYLASE; PHENYLKETONURIAS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TURKEY;

EUKARYOTA;

EID: 33749517317     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.05.006     Document Type: Article

References (29)

1. Scriver C.R., Waters P.J., Sarkission C., Ryan S., Prevost L., Cote D., Novak J., Teebi S., and Nowacki P.M. PAHdb: a locus -specific knowledgebase. Hum Genet. 15 (2000) 99-104
2. C.R. Scriver, S. Kaufman, Hyperphenylalaninemia; phenylalanine hydroxylase deficiency, in: C.R. Scriver, A. Beaudet, W.S. Sly, D. Walle (Eds.), B. Childs, K.W. Kinzler, B. Vogelstein (Assoc Eds.), The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New York, 2001, pp. 1667-1724.
3. J. Dunlon, H.L. Levy, C.R. Scriver, Hyperphenylalaninemia; phenylalanine hydroxylase deficiency. Chapter 77 Online. http://genetics.accessmedicine.com/.
4. C.R. Scriver, A. Beaudet, W.S. Sly, D. Walle, in: B. Childs, K.W. Kinzler, B. Vogelstein (Assoc Eds.), The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill Book Co., New York, 2005.
5. Le Marechal C., Audrezet M.P., Quere I., Raguenes O., Langonne S., and Ferec C. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (DHPLC): major implications for genetic counseling. Hum Genet. 15 1 (2000) 290-298
6. Wagner T.M., Moslinger R.A., Muhr D., Langbauer G., Hirtenlehner K., Concin H., Doeller W., Haid A., Lang A.H., Mayer P., Ropp E., Kubista E., Amirimani B., Helbich T., Becherer A., Scheiner O., Breiteneder H., Borg A., Devilee P., Oefner P., and Zielinski C. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int. J. Cancer 77 (1998) 354-366
7. Wagner T.M., Hirtenlehner K., Shen P., Moeslinger R., Muhr D., Fleischmann E., Concin H., Doller W., Haid A., Lang A.H., Mayer P., Petru E., Ropp E., Langbauer G., Kubista E., Ssheiner O., Underhill P., Mountain J., Stierer M., Zielinski C., and Oefner P. Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum. Mol. Genet. 8 3 (1999) 413-423
8. Brautigam S., Kujat A., Kirst P., Seidel J., Lüleyap H.U., and Froster U.G. DHPLC mutation analysis of phenylketonuria. Mol. Genet. Metabol. 78 (2003) 205-210
9. Erlandsen H., and Raymond Stevens C. The structural basis of phenyketonuria. Mol. Genet. Metabol. 68 (1999) 103-125
10. Salz H.K., Mancebo R.S., Nagengast A.A., Speck O., Psotka M., and Mount S.M. The Drosophila U1-70K protein is required for viability, but its arginine-rich domain is dispensable. Genetics 168 4 (2004) 2059-2065
11. Tsai C.C., and Fondell J.D. Nuclear receptor recruitment of histone-modifying enzymes to target gene promoters. Vitam. Horm. 68 (2004) 93-122
12. Funke S., Knechten T., Ollesch J., and Schünemann D. A unique sequence motif in the 54-kDa subunit of the chloroplast signal recognition particle mediates binding to the 43-kDa subunit. J. Biol. Chem. 280 10 (2005) 8912-8917
13. Kim A.Y., Shriver B., Quay T., and Hersh L.B. Analysis of the importance of arginine 102 in neutral endopeptidase (enkephalinase) catalysis. J. Biol. Chem. 267 17 (1992) 12330-12335
14. Giles I., Lambrianides N., Latchman D., Chen P., Chukwuocha R., Isenberg D., and Rahman A. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Arthritis. Res. Ther. 7 (2005) R47-R56
15. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16 (1988) 1215
16. Kayaalp E., Treacy E., Waters P.J., Byck S., Nowacki P., and Scriver C.R. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. Am. J. Hum. Genet. 61 (1997) 1309-1317
17. Eisensmith R.C., and Woo S.L. Molecular genetics of phenylketenuria: from molecular anthropology to gene therapy. Adv. Genet. 32 (1995) 199-271
18. Zschocke J. Phenyketonuria mutations in Europa. Hum. Mutat. 21 4 (2003) 345-356
19. Cali F., Dianzani I., Desviat L.R., Perez B., Ugarte M., Ozguc M., Seyrantepe V., Shiloh Y., Giannattasio S., Carducci C., Bosco P., De Leo G., Piazza A., and Romano V. The STR252-IVS10nt546-VNTR7 phenylalanine hydroxylase minihaplotype in five Mediterranean samples. Hum. Genet. 100 3/4 (1997) 350-355
20. Ozguc M., Ozalp I., Coskun T., Yilmaz E., Erdem H., and Ayter S. Mutation analysis in Turkish phenylketanuria patients. J. Med. Genet. 30 (1993) 129-130
21. Dianzoni I., Giannatsio S., de L., Sanctis M.E., Ponzone A., Camaschella C., and Piazza A. Genetic history of phenylketonuria mutations in Italy. Am. J. Hum. Genet. 55 (1994) 851-853
22. Guldberg P., Romona V., Ceratto N., Bosco P., Ciuna M., Indelicato A., Mollica F., Meli C., Giovannini M., Riva E., Biasucci G., Henriksen K.F., and Guntler F. Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninaemia in Southern Europa. Hum. Mol. Genet. 2 (1993) 1703-1707
23. Perez B., Desviat L.R., and Ugarte M. Analysis of the phenylalanine hydroxylase gene in the Spanish population. Mutation profile and association with intragenic polymorphic markers. Am. J. Hum. Genet. 60 (1997) 95-102
24. Rivera L., Leandro P., Lichter U.K., Tavares de Almeida L., and Lechner M.C. Population genetics of hyperphenylalaninaemia resulting from phenylalanine hydroxylase deficiency in Portugal. J. Med. Genet. 35 (1998) 301-304
25. Ulusoy M., and Tunçbilek E. Consanquineous marriages in Turkey and its effects on infant mortality. Nufusbil Derg. 9 (1987) 7-26
26. Byck S., Tyfield L., Carter K., and Scriver C.R. Prediction of multiple hypermutable codons in the human PAH gene: codon 280 contains recurrent mutations in Quebec and other populations. Hum. Mutat. 9 4 (1997) 316-321
27. Krawczak M., and Zschocke J. A role for overdominant selection in phenylketonuria? Evidence from molecular data. Hum. Mutat. 21 4 (2003) 394-397
28. Knight R.D., and Landweber L.F. Rhyme or reason: RNA-arginine interactions and the genetic code. Chem. Biol. 5 9 (1998) R215-R220
29. Yano M., Terada K., Umiji K., and Izui K. Catalytic role of an arginine residue in the highly conserved and unique sequence of phosphoenolpyruvate carboxylase. J. Biochem. (Tokyo) 117 6 (1995) 1196-1200